{
  "main_header": {
    "sid": 1249365,
    "name": "Cyclerion Therapeutics, Inc.",
    "stock_name": "Cyclerion Therapeutics, Inc.",
    "full_name": "Cyclerion Therapeutics, Inc.",
    "name_url": "stocks-analysis/cyclerion-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.70",
    "chg": 0.17,
    "chgp": "11.11%",
    "dir": 1,
    "prev_price": "1.53",
    "mcapval": "7.54",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US23255M2044",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "43.38 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cyclerion-therapeutics-inc-1249365-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Cyclerion Therapeutics, Inc. Announces Revision in Its Stock Evaluation Amid Financial Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cyclerion-therapeutics-financial-trend-shifts-from-positive-to-very-positive-amid-mixed-performance-metrics-3715756",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CyclerionTherap_fintrenddot_3715756.png",
        "date": "2025-11-19 15:44:47",
        "description": "Cyclerion Therapeutics, Inc. reported flat financial performance for the quarter ending June 2025, highlighting both strengths and challenges. Key metrics included a peak operating cash flow and net profit for the half-year, but the company also faced high debt levels and significant operating losses amid market volatility."
      }
    ],
    "total": 5,
    "sid": "1249365",
    "stock_news_url": "https://www.marketsmojo.com/news/cyclerion-therapeutics-inc-1249365"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Cyclerion Therapeutics, Inc. Announces Revision in Its Stock Evaluation Amid Financial Trends

2025-11-19 15:44:47

Cyclerion Therapeutics, Inc. reported flat financial performance for the quarter ending June 2025, highlighting both strengths and challenges. Key metrics included a peak operating cash flow and net profit for the half-year, but the company also faced high debt levels and significant operating losses amid market volatility.

Read More

View All News